Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Safehouse is a Philadelphia-based non-profit healthcare organization dedicated to overdose prevention and harm reduction. The organization is best known for its efforts to establish the first supervised injection site in the United States, providing a medically supervised environment for individuals to consume pre-obtained substances. Beyond supervised consumption, Safehouse offers a comprehensive suite of public health services, including the administration of naloxone for overdose reversal, initiation of medically assisted treatment (MAT), and wound care. They also provide critical diagnostic services such as HIV and Hepatitis C testing, alongside referrals to social services like housing and legal aid. Safehouse has been at the center of significant federal litigation regarding the legality of supervised consumption sites under the Controlled Substances Act.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safehouse Services.